Mon, January 14, 2019
Fri, January 11, 2019
Thu, January 10, 2019
Wed, January 9, 2019
Tue, January 8, 2019
Mon, January 7, 2019
Fri, January 4, 2019
Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018

Jack Meehan Upgraded (BIO) to Buy and Held Target at $315 on, Jan 3rd, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-315-on-jan-3rd-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Jack Meehan of Barclays, Upgraded "Bio-Rad Laboratories, Inc." (BIO) to Buy and Held Target at $315 on, Jan 3rd, 2019.

Jack has made no other calls on BIO in the last 4 months.



There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 1 agrees with Jack's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Steve Beuchaw of "Morgan Stanley" Initiated at Hold and Held Target at $335 on, Thursday, September 20th, 2018


This is the rating of the analyst that currently disagrees with Jack


  • Patrick Donnelly of "Goldman Sachs" Initiated at Strong Buy and Held Target at $350 on, Wednesday, October 17th, 2018

Publication Contributing Sources